Literature DB >> 10788758

Excessive ethanol drinking following a history of dependence: animal model of allostasis.

A J Roberts1, C J Heyser, M Cole, P Griffin, G F Koob.   

Abstract

Alcohol withdrawal symptoms, particularly negative emotional states, can persist for months following the removal of alcohol. These protracted withdrawal symptoms have been implicated as an important trigger of relapse to excessive drinking in alcoholics and may represent a long lasting shift in affective tone as a result of chronic alcohol exposure. It was shown previously that ethanol-dependent rats increased their operant responding for ethanol when tested during the first 12 hr after withdrawal. The purpose of the present experiments was to determine the persistence of this finding by examining operant oral ethanol self-administration in rats with a history of physical dependence upon ethanol, detoxified and then allowed a two week period of protracted abstinence. The results of these experiments indicate that operant responding for ethanol was enhanced during protracted abstinence by 30-100% and remained elevated for 4-8 weeks post acute withdrawal. These results have important implications for understanding the characteristics and mechanisms underlying vulnerability to relapse.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10788758     DOI: 10.1016/S0893-133X(99)00167-0

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  187 in total

1.  Persistent escalation of alcohol drinking in C57BL/6J mice with intermittent access to 20% ethanol.

Authors:  Lara S Hwa; Adam Chu; Sally A Levinson; Tala M Kayyali; Joseph F DeBold; Klaus A Miczek
Journal:  Alcohol Clin Exp Res       Date:  2011-06-01       Impact factor: 3.455

Review 2.  Preclinical studies of alcohol binge drinking.

Authors:  John C Crabbe; R Adron Harris; George F Koob
Journal:  Ann N Y Acad Sci       Date:  2011-01       Impact factor: 5.691

Review 3.  The validity of the reinstatement model of craving and relapse to drug use.

Authors:  Jonathan L Katz; Stephen T Higgins
Journal:  Psychopharmacology (Berl)       Date:  2003-04-15       Impact factor: 4.530

Review 4.  Functional genomics strategies to identify susceptibility genes and treatment targets in alcohol dependence.

Authors:  Markus Heilig; Wolfgang Sommer
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

5.  Effects of prolonged ethanol vapor exposure on forced swim behavior, and neuropeptide Y and corticotropin-releasing factor levels in rat brains.

Authors:  Brendan M Walker; David A Drimmer; Jennifer L Walker; Tianmin Liu; Aleksander A Mathé; Cindy L Ehlers
Journal:  Alcohol       Date:  2010-08-12       Impact factor: 2.405

Review 6.  Chronic alcohol neuroadaptation and stress contribute to susceptibility for alcohol craving and relapse.

Authors:  George R Breese; Rajita Sinha; Markus Heilig
Journal:  Pharmacol Ther       Date:  2010-10-15       Impact factor: 12.310

7.  The role of matrix metalloproteinase-9 in negative reinforcement learning and plasticity in alcohol dependence.

Authors:  Bok Soon Go; Sunil Sirohi; Brendan M Walker
Journal:  Addict Biol       Date:  2019-01-16       Impact factor: 4.280

8.  Effects of concurrent access to multiple ethanol concentrations and repeated deprivations on alcohol intake of high-alcohol-drinking (HAD) rats.

Authors:  Zachary A Rodd; Richard L Bell; Kelly A Kuc; James M Murphy; Lawrence Lumeng; William J McBride
Journal:  Addict Biol       Date:  2008-12-12       Impact factor: 4.280

9.  Animal models of excessive alcohol consumption: recent advances and future challenges.

Authors:  Howard C Becker; Dorit Ron
Journal:  Alcohol       Date:  2014-04-08       Impact factor: 2.405

10.  Dendritic remodeling of hippocampal neurons is associated with altered NMDA receptor expression in alcohol dependent rats.

Authors:  Miranda C Staples; Airee Kim; Chitra D Mandyam
Journal:  Mol Cell Neurosci       Date:  2015-03-10       Impact factor: 4.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.